nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—HTR2C—telencephalic ventricle—Parkinson's disease	0.0249	0.14	CbGeAlD
Metixene—CHRM4—head—Parkinson's disease	0.00719	0.0405	CbGeAlD
Metixene—CHRM4—nervous system—Parkinson's disease	0.00681	0.0384	CbGeAlD
Metixene—CHRM2—forebrain—Parkinson's disease	0.00673	0.038	CbGeAlD
Metixene—HTR2C—brainstem—Parkinson's disease	0.00672	0.0379	CbGeAlD
Metixene—CHRM4—central nervous system—Parkinson's disease	0.00656	0.037	CbGeAlD
Metixene—HTR2C—forebrain—Parkinson's disease	0.00649	0.0366	CbGeAlD
Metixene—CHRM1—forebrain—Parkinson's disease	0.00613	0.0346	CbGeAlD
Metixene—CHRM2—cardiovascular system—Parkinson's disease	0.00569	0.0321	CbGeAlD
Metixene—CHRM5—head—Parkinson's disease	0.00562	0.0317	CbGeAlD
Metixene—CHRM3—forebrain—Parkinson's disease	0.00548	0.0309	CbGeAlD
Metixene—CHRM5—nervous system—Parkinson's disease	0.00533	0.03	CbGeAlD
Metixene—CHRM4—brain—Parkinson's disease	0.00521	0.0294	CbGeAlD
Metixene—CHRM1—cardiovascular system—Parkinson's disease	0.00518	0.0292	CbGeAlD
Metixene—CHRM5—central nervous system—Parkinson's disease	0.00513	0.0289	CbGeAlD
Metixene—HTR2C—medulla oblongata—Parkinson's disease	0.00469	0.0264	CbGeAlD
Metixene—HTR2C—midbrain—Parkinson's disease	0.00429	0.0242	CbGeAlD
Metixene—HTR2C—spinal cord—Parkinson's disease	0.00418	0.0236	CbGeAlD
Metixene—CHRM5—brain—Parkinson's disease	0.00407	0.023	CbGeAlD
Metixene—CHRM2—head—Parkinson's disease	0.00386	0.0217	CbGeAlD
Metixene—HTR2C—head—Parkinson's disease	0.00372	0.021	CbGeAlD
Metixene—CHRM2—nervous system—Parkinson's disease	0.00366	0.0206	CbGeAlD
Metixene—HTR2C—nervous system—Parkinson's disease	0.00352	0.0199	CbGeAlD
Metixene—CHRM2—central nervous system—Parkinson's disease	0.00352	0.0198	CbGeAlD
Metixene—CHRM1—head—Parkinson's disease	0.00351	0.0198	CbGeAlD
Metixene—HTR2C—central nervous system—Parkinson's disease	0.00339	0.0191	CbGeAlD
Metixene—CHRM1—nervous system—Parkinson's disease	0.00333	0.0188	CbGeAlD
Metixene—CHRM1—central nervous system—Parkinson's disease	0.0032	0.0181	CbGeAlD
Metixene—CHRM3—head—Parkinson's disease	0.00314	0.0177	CbGeAlD
Metixene—CHRM3—nervous system—Parkinson's disease	0.00298	0.0168	CbGeAlD
Metixene—CHRM3—central nervous system—Parkinson's disease	0.00287	0.0162	CbGeAlD
Metixene—CHRM2—brain—Parkinson's disease	0.00279	0.0158	CbGeAlD
Metixene—Diphenylpyraline—SLC6A3—Parkinson's disease	0.00271	0.043	CrCbGaD
Metixene—HTR2C—brain—Parkinson's disease	0.00269	0.0152	CbGeAlD
Metixene—CHRM1—brain—Parkinson's disease	0.00254	0.0143	CbGeAlD
Metixene—CHRM3—brain—Parkinson's disease	0.00228	0.0128	CbGeAlD
Metixene—Maprotiline—HTR7—Parkinson's disease	0.0022	0.0349	CrCbGaD
Metixene—Mirtazapine—HTR7—Parkinson's disease	0.00201	0.032	CrCbGaD
Metixene—Maprotiline—SLC6A3—Parkinson's disease	0.00193	0.0306	CrCbGaD
Metixene—Mirtazapine—DRD3—Parkinson's disease	0.00189	0.03	CrCbGaD
Metixene—Mirtazapine—SLC6A3—Parkinson's disease	0.00176	0.028	CrCbGaD
Metixene—Mesoridazine—DRD3—Parkinson's disease	0.00159	0.0252	CrCbGaD
Metixene—Protriptyline—CYP2D6—Parkinson's disease	0.00159	0.0252	CrCbGaD
Metixene—Mirtazapine—HTR1A—Parkinson's disease	0.00154	0.0245	CrCbGaD
Metixene—Prochlorperazine—DRD3—Parkinson's disease	0.00154	0.0244	CrCbGaD
Metixene—Cyproheptadine—HTR1A—Parkinson's disease	0.0015	0.0238	CrCbGaD
Metixene—Mianserin—HTR7—Parkinson's disease	0.00148	0.0235	CrCbGaD
Metixene—Maprotiline—DRD2—Parkinson's disease	0.00143	0.0227	CrCbGaD
Metixene—Mianserin—DRD3—Parkinson's disease	0.00139	0.0221	CrCbGaD
Metixene—Mirtazapine—DRD2—Parkinson's disease	0.00131	0.0208	CrCbGaD
Metixene—Mesoridazine—HTR1A—Parkinson's disease	0.00129	0.0206	CrCbGaD
Metixene—Mianserin—SLC6A3—Parkinson's disease	0.00129	0.0205	CrCbGaD
Metixene—Thioridazine—HTR7—Parkinson's disease	0.00127	0.0202	CrCbGaD
Metixene—Cyproheptadine—DRD2—Parkinson's disease	0.00127	0.0202	CrCbGaD
Metixene—Thioridazine—DRD1—Parkinson's disease	0.00118	0.0187	CrCbGaD
Metixene—Quetiapine—HTR7—Parkinson's disease	0.00115	0.0182	CrCbGaD
Metixene—Mianserin—HTR1A—Parkinson's disease	0.00113	0.018	CrCbGaD
Metixene—Protriptyline—ABCB1—Parkinson's disease	0.00113	0.018	CrCbGaD
Metixene—Maprotiline—HTR2A—Parkinson's disease	0.00111	0.0176	CrCbGaD
Metixene—Mequitazine—CYP2D6—Parkinson's disease	0.00111	0.0176	CrCbGaD
Metixene—Mesoridazine—DRD2—Parkinson's disease	0.0011	0.0175	CrCbGaD
Metixene—Quetiapine—DRD3—Parkinson's disease	0.00108	0.0171	CrCbGaD
Metixene—Prochlorperazine—DRD2—Parkinson's disease	0.00106	0.0169	CrCbGaD
Metixene—Quetiapine—DRD1—Parkinson's disease	0.00106	0.0168	CrCbGaD
Metixene—Mirtazapine—HTR2A—Parkinson's disease	0.00101	0.0161	CrCbGaD
Metixene—Maprotiline—CYP2D6—Parkinson's disease	0.00101	0.0161	CrCbGaD
Metixene—Cyproheptadine—HTR2A—Parkinson's disease	0.000981	0.0156	CrCbGaD
Metixene—Thioridazine—HTR1A—Parkinson's disease	0.000977	0.0155	CrCbGaD
Metixene—Promazine—DRD1—Parkinson's disease	0.000973	0.0155	CrCbGaD
Metixene—Mianserin—DRD2—Parkinson's disease	0.000962	0.0153	CrCbGaD
Metixene—Mirtazapine—CYP2D6—Parkinson's disease	0.000925	0.0147	CrCbGaD
Metixene—Quetiapine—HTR1A—Parkinson's disease	0.000879	0.014	CrCbGaD
Metixene—Mesoridazine—HTR2A—Parkinson's disease	0.000849	0.0135	CrCbGaD
Metixene—Thioridazine—DRD2—Parkinson's disease	0.000829	0.0132	CrCbGaD
Metixene—Thioridazine—CYP2E1—Parkinson's disease	0.000798	0.0127	CrCbGaD
Metixene—Promethazine—DRD2—Parkinson's disease	0.00078	0.0124	CrCbGaD
Metixene—Mesoridazine—CYP2D6—Parkinson's disease	0.000777	0.0123	CrCbGaD
Metixene—Prochlorperazine—CYP2D6—Parkinson's disease	0.000752	0.0119	CrCbGaD
Metixene—Quetiapine—DRD2—Parkinson's disease	0.000746	0.0118	CrCbGaD
Metixene—Mianserin—HTR2A—Parkinson's disease	0.000744	0.0118	CrCbGaD
Metixene—Maprotiline—ABCB1—Parkinson's disease	0.000722	0.0115	CrCbGaD
Metixene—Promazine—DRD2—Parkinson's disease	0.000686	0.0109	CrCbGaD
Metixene—Mianserin—CYP2D6—Parkinson's disease	0.00068	0.0108	CrCbGaD
Metixene—Thioridazine—HTR2A—Parkinson's disease	0.000641	0.0102	CrCbGaD
Metixene—Promethazine—HTR2A—Parkinson's disease	0.000602	0.00957	CrCbGaD
Metixene—Thioridazine—CYP2D6—Parkinson's disease	0.000586	0.0093	CrCbGaD
Metixene—Quetiapine—HTR2A—Parkinson's disease	0.000577	0.00916	CrCbGaD
Metixene—Promethazine—CYP2D6—Parkinson's disease	0.000551	0.00875	CrCbGaD
Metixene—Promazine—HTR2A—Parkinson's disease	0.00053	0.00842	CrCbGaD
Metixene—Quetiapine—CYP2D6—Parkinson's disease	0.000527	0.00837	CrCbGaD
Metixene—Promethazine—ABCB1—Parkinson's disease	0.000393	0.00625	CrCbGaD
Metixene—Quetiapine—ABCB1—Parkinson's disease	0.000377	0.00598	CrCbGaD
Metixene—HTR2C—Signaling Pathways—PENK—Parkinson's disease	0.000277	0.000364	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MAG—Parkinson's disease	0.000277	0.000364	CbGpPWpGaD
Metixene—CHRM3—Metabolism—DDC—Parkinson's disease	0.000276	0.000363	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000276	0.000363	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000275	0.000363	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD3—Parkinson's disease	0.000275	0.000362	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000275	0.000361	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD2—Parkinson's disease	0.000274	0.000361	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HTR7—Parkinson's disease	0.000274	0.000361	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000272	0.000358	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00027	0.000356	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000269	0.000354	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	0.000269	0.000354	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000267	0.000351	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—FGF20—Parkinson's disease	0.000264	0.000348	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000262	0.000344	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000261	0.000343	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000261	0.000343	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000258	0.00034	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000257	0.000338	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADORA2A—Parkinson's disease	0.000256	0.000338	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000256	0.000337	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—EDN1—Parkinson's disease	0.000255	0.000336	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000254	0.000334	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	0.000253	0.000333	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PDYN—Parkinson's disease	0.000253	0.000333	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000253	0.000333	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000252	0.000332	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.000251	0.000331	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000251	0.00033	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.00025	0.000329	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000249	0.000328	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000249	0.000328	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	0.000249	0.000327	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	0.000249	0.000327	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000247	0.000325	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000246	0.000323	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	0.000246	0.000323	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000245	0.000323	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.000244	0.000322	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	0.000244	0.000322	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000244	0.000322	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000243	0.000321	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000242	0.000319	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000241	0.000317	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000239	0.000315	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000239	0.000315	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000238	0.000314	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000238	0.000314	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	0.000238	0.000313	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000238	0.000313	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000237	0.000312	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—INSR—Parkinson's disease	0.000237	0.000312	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000237	0.000311	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000237	0.000311	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000236	0.000311	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000236	0.000311	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000236	0.00031	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000236	0.00031	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	0.000235	0.00031	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000235	0.00031	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000235	0.000309	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000234	0.000309	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000234	0.000307	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000234	0.000307	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000232	0.000306	CbGpPWpGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00023	0.000303	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—INSR—Parkinson's disease	0.000227	0.000298	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—FGB—Parkinson's disease	0.000224	0.000294	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	0.000223	0.000294	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	0.000222	0.000293	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000222	0.000292	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000221	0.000291	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000219	0.000289	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	0.000219	0.000288	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000219	0.000288	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000219	0.000288	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000218	0.000287	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000216	0.000284	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	0.000215	0.000283	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000215	0.000283	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000215	0.000283	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—FGB—Parkinson's disease	0.000214	0.000282	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000214	0.000282	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000214	0.000282	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	0.000214	0.000281	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	0.000213	0.00028	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000212	0.000279	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000212	0.000279	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	0.00021	0.000276	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000209	0.000275	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	0.000208	0.000274	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	0.000206	0.000272	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	0.000206	0.000271	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000206	0.000271	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000205	0.00027	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000203	0.000268	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000203	0.000267	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000203	0.000267	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000201	0.000264	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.0002	0.000264	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	0.000199	0.000262	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	0.000199	0.000262	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	0.000194	0.000256	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000192	0.000253	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.00019	0.000251	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000189	0.000249	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000189	0.000249	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	0.000188	0.000248	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	0.000188	0.000248	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000187	0.000246	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	0.000186	0.000245	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—INSR—Parkinson's disease	0.000185	0.000243	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00018	0.000238	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	0.00018	0.000237	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	0.00018	0.000237	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00018	0.000237	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000178	0.000235	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000178	0.000234	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000176	0.000232	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—FGB—Parkinson's disease	0.000175	0.00023	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000174	0.000229	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	0.000174	0.000229	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000173	0.000228	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000173	0.000227	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000172	0.000227	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000172	0.000226	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000171	0.000226	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	0.000171	0.000225	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000171	0.000225	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.00017	0.000223	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CTGF—Parkinson's disease	0.00017	0.000223	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	0.000168	0.000221	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000166	0.000218	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000165	0.000217	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000164	0.000215	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	0.000162	0.000214	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.00016	0.00021	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.000159	0.000209	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000158	0.000208	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	0.000158	0.000208	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000158	0.000207	CbGpPWpGaD
Metixene—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000156	0.000206	CbGpPWpGaD
Metixene—CHRM3—Metabolism—TH—Parkinson's disease	0.000154	0.000203	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	0.000152	0.000201	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000152	0.0002	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	0.000151	0.000199	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000151	0.000199	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	0.000151	0.000198	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.00015	0.000198	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.00015	0.000198	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.00015	0.000197	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.00015	0.000197	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.00015	0.000197	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000149	0.000196	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000149	0.000196	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000148	0.000195	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000148	0.000195	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000148	0.000194	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000147	0.000194	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	0.000147	0.000193	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	0.000147	0.000193	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	0.000146	0.000192	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.000146	0.000192	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000145	0.000191	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.000144	0.00019	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	0.000144	0.00019	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000143	0.000188	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.00014	0.000185	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.00014	0.000184	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000139	0.000182	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—NGF—Parkinson's disease	0.000138	0.000182	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—NGF—Parkinson's disease	0.000133	0.000175	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	0.000132	0.000174	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000131	0.000172	CbGpPWpGaD
Metixene—CHRM3—Metabolism—COMT—Parkinson's disease	0.000131	0.000172	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000131	0.000172	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.00013	0.000171	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MAOA—Parkinson's disease	0.00013	0.000171	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000129	0.00017	CbGpPWpGaD
Metixene—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000128	0.000169	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000127	0.000167	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000127	0.000167	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000126	0.000167	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000126	0.000167	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	0.000126	0.000166	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.000125	0.000165	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.000125	0.000165	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000123	0.000162	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	0.000123	0.000162	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—APOE—Parkinson's disease	0.000123	0.000161	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.00012	0.000158	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	0.000119	0.000157	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	0.000118	0.000155	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—APOE—Parkinson's disease	0.000117	0.000154	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000115	0.000151	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NGF—Parkinson's disease	0.000108	0.000142	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000106	0.00014	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000106	0.00014	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000106	0.000139	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000105	0.000138	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—INS—Parkinson's disease	0.000105	0.000138	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	0.000103	0.000135	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000103	0.000135	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000102	0.000135	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000102	0.000134	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000101	0.000134	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000101	0.000133	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.0001	0.000132	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—INS—Parkinson's disease	0.0001	0.000132	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APOE—Parkinson's disease	9.85e-05	0.00013	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APOE—Parkinson's disease	9.57e-05	0.000126	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NGF—Parkinson's disease	9.34e-05	0.000123	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NGF—Parkinson's disease	9.31e-05	0.000123	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NGF—Parkinson's disease	9.22e-05	0.000121	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	8.89e-05	0.000117	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	8.86e-05	0.000117	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	8.77e-05	0.000115	CbGpPWpGaD
Metixene—CHRM3—Metabolism—INS—Parkinson's disease	8.42e-05	0.000111	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APOE—Parkinson's disease	8.26e-05	0.000109	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APOE—Parkinson's disease	8.24e-05	0.000108	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—INS—Parkinson's disease	8.17e-05	0.000108	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APOE—Parkinson's disease	8.16e-05	0.000107	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	7.79e-05	0.000103	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	7.74e-05	0.000102	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	7.46e-05	9.83e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	7.42e-05	9.76e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	7.16e-05	9.43e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—INS—Parkinson's disease	7.06e-05	9.29e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—INS—Parkinson's disease	7.04e-05	9.26e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—INS—Parkinson's disease	6.97e-05	9.17e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	6.86e-05	9.03e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	6.08e-05	8.01e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	6.05e-05	7.96e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	5.59e-05	7.36e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	5.26e-05	6.92e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	5.24e-05	6.9e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	5.22e-05	6.87e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	5.2e-05	6.85e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	5.19e-05	6.83e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	5.15e-05	6.78e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	4.83e-05	6.36e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	4.81e-05	6.34e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	4.77e-05	6.28e-05	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IL6—Parkinson's disease	4.57e-05	6.02e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IL6—Parkinson's disease	4.38e-05	5.77e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IL6—Parkinson's disease	3.57e-05	4.7e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IL6—Parkinson's disease	3.08e-05	4.06e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IL6—Parkinson's disease	3.07e-05	4.05e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IL6—Parkinson's disease	3.04e-05	4.01e-05	CbGpPWpGaD
